Brain Health
Dasatinib and Quercetin Reach the Brain in Early Alzheimer's Patients
A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.
Clinical Trial
May 28, 2026 0
Results for "Quercetin Senolytic" in Alzheimer's
20 articles
Brain Health
Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
Clinical Trial
Mar 28, 2026 2
Brain Health
Retired Cholesterol Drug Shows Promise for Alzheimer's Prevention in Small Trial
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Clinical Trial
Mar 29, 2026 0
Brain Health
Cilostazol Tested Against Cognitive Decline in Mild Cognitive Impairment
A Phase 2 trial explores whether cilostazol, a blood thinner with brain-protective effects, can slow memory loss in MCI patients.
Clinical Trial
Jun 27, 2026 0
Brain Health
Nordic Berries Put to the Test for Fighting Age-Related Cognitive Decline
A completed trial tests whether daily Nordic berry beverages can sharpen cognition in healthy adults over 12 weeks.
Clinical Trial
Jun 14, 2026 0
Brain Health
Drugs That Boost Brain Waste Clearance During Sleep Show Promise Against Alzheimer's
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
Clinical Trial
May 16, 2026 0
Brain Health
Bioavailable Turmeric Supplement Tested Against Cognitive Decline in Metabolic Syndrome
The EPICURO trial tests MERIVA® turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
Clinical Trial
May 7, 2026 0
Brain Health
New Drug Shows Promise in Preventing Alzheimer's Amyloid Buildup in Young Adults
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
Clinical Trial
Mar 28, 2026 0
Brain Health
Carnosine Supplement Targets Neuromuscular Decline in Multiple Sclerosis
A completed pilot trial tests whether 2g/day of a novel carnosine formulation can restore neuromuscular function and quality of life in MS patients.
Clinical Trial
Jun 17, 2026 0
Brain Health
Green Tea Extract Plus Lifestyle Changes Tested Against Cognitive Decline in High-Risk Adults
A completed trial tests EGCG combined with diet, exercise, and cognitive training to slow decline in ApoE4 carriers with early warning signs.
Clinical Trial
May 15, 2026 0
Brain Health
Oral All-D-Peptide Contraloid Advances to Human Safety Trial for Alzheimer's
A first-in-human multiple-ascending-dose trial tests Contraloid, an oral peptide designed to disassemble toxic amyloid-beta oligomers linked to Alzheimer's disease.
Clinical Trial
Jun 17, 2026 0
Brain Health
First Human Trial of Oral D-Peptide Drug Targeting Alzheimer's Toxic Oligomers Completed
Contraloid acetate, an oral all-D-peptide designed to disassemble toxic amyloid-beta oligomers, completed its first-in-human safety trial in 40 healthy volunteers.
Clinical Trial
Jun 12, 2026 0
Brain Health
Microalgae Supplement BrainPhyt Shows Promise for Cognitive Health in Older Adults
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
Clinical Trial
Mar 28, 2026 0
Brain Health
Simufilam Alzheimer's Trial Terminated Before Completing Phase 3
Cassava Sciences' 76-week Phase 3 trial of simufilam for Alzheimer's was terminated, raising questions about the drug's future.
Clinical Trial
Jun 1, 2026 0
Brain Health
Repurposed Anti-Nausea Drug TEP Tested for Clearing Alzheimer's Brain Plaques
A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.
Clinical Trial
Jun 12, 2026 0
Brain Health
BACE Inhibitor Atabecestat Trial in Pre-Symptomatic Alzheimer's Risk Terminated Early
A phase 2/3 trial of the BACE inhibitor atabecestat in amyloid-positive asymptomatic adults was terminated before completion, raising questions about this drug class.
Clinical Trial
May 13, 2026 0
Brain Health
Antiviral Drug Valacyclovir Tested to Slow Alzheimer's Progression in MCI Patients
A Phase II trial tests whether blocking herpes virus activity can protect against Alzheimer's disease in early cognitive decline.
Clinical Trial
Jun 6, 2026 0
Brain Health
Alpha-Lipoic Acid Added to Flunarizine Tested for Teen Migraine Prevention
A completed Phase 4 trial from India evaluates whether ALA supplementation boosts flunarizine's migraine-prevention power in adolescents.
Clinical Trial
Jun 17, 2026 0
Brain Health
Rural Community Program Targets Alzheimer's Risk Through Lifestyle Interventions
Small pilot study tests multicomponent behavioral program to reduce cognitive decline risk in underserved rural populations.
Clinical Trial
Mar 28, 2026 1
Brain Health
Home-Based Exercise and Brain Training Tackles Cognitive Decline in Older Adults
A Canadian RCT tests whether virtual aerobic, resistance, and cognitive training can feasibly combat mild cognitive impairment at home.
Clinical Trial
Jul 3, 2026 0
Page 1 of 2Next